13-20631001-A-T

Variant names:

• chr13-20631001-A-T
• rs1329519
• NM_006531.5:c.1300-15A>T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_Strong BP6_Very_Strong BA1

The NM_006531.5(IFT88):​c.1300-15A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.735 in 1,462,846 control chromosomes in the GnomAD database, including 400,386 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

• Frequency:
  • Genomes: 𝑓 0.70 (37816 hom., cov: 31)
  • Exomes 𝑓: 0.74 (362570 hom.)
• Consequence: IFT88 NM_006531.5 intron
• Clinical Significance: Benign criteria provided, multiple submitters, no conflicts B:3
• Conservation: PhyloP100: 0.109

Genes affected

IFT88 (HGNC:20606): (intraflagellar transport 88) This gene encodes a member of the tetratrico peptide repeat (TPR) family. The encoded protein is involved in cilium biogenesis. Mutations of a similar gene in mouse can cause polycystic kidney disease. Several transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2017]

ACMG classification

Verdict is Benign. Variant got -20 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.79).
• BP6: Variant 13-20631001-A-T is Benign according to our data. Variant chr13-20631001-A-T is described in ClinVar as [Benign]. Clinvar id is 402966.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-20631001-A-T is described in Lovd as [Benign].
• BA1: GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.973 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
IFT88	NM_006531.5	c.1300-15A>T		intron_variant	Intron 15 of 25	ENST00000351808.10	NP_006522.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
IFT88	ENST00000351808.10	c.1300-15A>T		intron_variant	Intron 15 of 25	1	NM_006531.5	ENSP00000261632.5

Frequencies

GnomAD3 genomes AF: 0.696 AC: 105641 AN: 151826 Hom.: 37800 Cov.: 31

Gnomad AFR AF: 0.540

Gnomad AMI AF: 0.749

Gnomad AMR AF: 0.778

Gnomad ASJ AF: 0.687

Gnomad EAS AF: 0.996

Gnomad SAS AF: 0.885

Gnomad FIN AF: 0.746

Gnomad MID AF: 0.725

Gnomad NFE AF: 0.726

Gnomad OTH AF: 0.718

GnomAD3 exomes AF: 0.770 AC: 192903 AN: 250504 Hom.: 75893 AF XY: 0.774 AC XY: 104886 AN XY: 135436

Gnomad AFR exome AF: 0.531

Gnomad AMR exome AF: 0.854

Gnomad ASJ exome AF: 0.694

Gnomad EAS exome AF: 0.997

Gnomad SAS exome AF: 0.878

Gnomad FIN exome AF: 0.748

Gnomad NFE exome AF: 0.725

Gnomad OTH exome AF: 0.740

GnomAD4 exome AF: 0.740 AC: 969548 AN: 1310902 Hom.: 362570 Cov.: 19 AF XY: 0.745 AC XY: 492163 AN XY: 660512

Gnomad4 AFR exome AF: 0.519

Gnomad4 AMR exome AF: 0.843

Gnomad4 ASJ exome AF: 0.683

Gnomad4 EAS exome AF: 0.998

Gnomad4 SAS exome AF: 0.871

Gnomad4 FIN exome AF: 0.745

Gnomad4 NFE exome AF: 0.722

Gnomad4 OTH exome AF: 0.735

GnomAD4 genome AF: 0.696 AC: 105703 AN: 151944 Hom.: 37816 Cov.: 31 AF XY: 0.705 AC XY: 52309 AN XY: 74240

Gnomad4 AFR AF: 0.540

Gnomad4 AMR AF: 0.779

Gnomad4 ASJ AF: 0.687

Gnomad4 EAS AF: 0.996

Gnomad4 SAS AF: 0.885

Gnomad4 FIN AF: 0.746

Gnomad4 NFE AF: 0.726

Gnomad4 OTH AF: 0.719

Alfa AF: 0.672 Hom.: 4398

Bravo AF: 0.688

Asia WGS AF: 0.915 AC: 3179 AN: 3478

ClinVar

Significance: Benign

Submissions summary: Benign:3

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

not provided Benign:2

-

Breakthrough Genomics, Breakthrough Genomics

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: not provided

- -

Feb 03, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

not specified Benign:1

Mar 29, 2016

Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.79
CADD	Benign	7.4
DANN	Benign	0.79

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs1329519; hg19: chr13-21205140;